Jul 13, 2026 06:41AM
Jun 25, 2026 07:12AM
Jun 25, 2026 06:48AM
Jun 25, 2026 02:59AM
Jun 25, 2026 02:59AM
Jun 1, 2026 06:57AM
May 27, 2026 06:44AM H.C. Wainwright Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)
Apr 29, 2026 04:10PM
Apr 29, 2026 07:00AM
Apr 28, 2026 02:06AM
Apr 28, 2026 02:06AM
Apr 21, 2026 07:03AM
Apr 21, 2026 07:00AM
Mar 25, 2026 03:42PM RBC Capital Reiterates Outperform Rating on Ionis Pharmaceuticals (IONS)
Mar 25, 2026 12:24PM
Mar 25, 2026 11:44AM
Mar 25, 2026 10:13AM
Mar 23, 2026 07:00AM
Mar 23, 2026 07:00AM
Feb 26, 2026 07:00AM
Feb 26, 2026 07:00AM FDA accepts Ionis' olezarsen application for priority review
Feb 26, 2026 07:00AM
Feb 25, 2026 07:00AM
Feb 4, 2026 07:30AM
Feb 4, 2026 07:30AM
Jul 30, 2025 07:00AM
Jul 21, 2025 07:00AM
Jul 21, 2025 07:00AM Phase 3 OASISplus data demonstrating benefit of donidalorsen for HAE patients who switched from other prophylactics published in JACI In Practice
Apr 30, 2025 07:00AM
Apr 7, 2025 06:34AM
Feb 20, 2025 07:03AM
Feb 20, 2025 07:00AM
Feb 20, 2025 05:50AM
Feb 19, 2025 02:52PM
Feb 19, 2025 07:00AM Ionis reports fourth quarter and full year 2024 financial results
Dec 20, 2024 07:18AM
Nov 6, 2024 07:00AM
Nov 4, 2024 09:45AM
Nov 4, 2024 09:44AM
Sep 26, 2024 06:23AM
Aug 1, 2024 07:00AM
Jun 25, 2024 06:55AM Ionis Pharmaceuticals (IONS) announces olezarsen FCS New Drug Application accepted for Priority Review and enrollment in Phase 3 sHTG program completed
Jun 25, 2024 06:55AM
Mar 13, 2024 03:02PM
Oct 4, 2023 07:00AM
Sep 28, 2023 12:02PM
Aug 9, 2023 07:00AM
Jul 31, 2023 07:05AM
Jul 28, 2023 07:05AM Ionis Pharmaceuticals (IONS) Expands eplontersen Deal with AstraZeneca (AZN) to Include Latin America
Jul 28, 2023 07:05AM

15,546 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All